Sarcopenic obesity: the role of oxidative stress in its development and the benefits of flavonoids in its treatment
Sarcopenic obesity (SO) is an excessive accumulation of adipose tissue, combined with loss of muscle mass and strength, progressing with age. This condition increases the risk of developing metabolic syndrome, cardiovascular diseases, osteoporosis, dementia, lung pathology, liver disease, and type 2 diabetes. Its pathogenesis is complex and includes insulin resistance, inflammation, hormonal and age-related changes, decreased physical activity, and poor nutrition. Oxidative stress is the main mechanism underlying all these processes. A number of studies indicate the protective role of antioxidant flavonoids in the treatment of SO. This literature review analyzes the role of oxidative stress in the development of SO and the potential benefits of flavonoids in its treatment.
Authors
- Lyudmila A. Sharonova (ORCID: https://orcid.org/0000-0001-8827-4919)
- E. V. Treneva (ORCID: https://orcid.org/0000-0003-0097-7252)
- Svetlana Viktorovna Bulgakova (ORCID: https://orcid.org/0000-0003-0027-1786)
- О В Косарева (ORCID: https://orcid.org/0009-0006-4531-9682)
- Yu. A. Dolgikh (ORCID: https://orcid.org/0000-0001-6678-6411)
- Nikolay A. Pervyshin (ORCID: https://orcid.org/0000-0002-9609-2725)
- Романчук Петр Иванович (ORCID: https://orcid.org/0000-0002-0603-1014)
- P. Ya. Merzlova (ORCID: https://orcid.org/0009-0004-6243-6528)
- Dmitrii P. Kurmaev (ORCID: https://orcid.org/0000-0003-4114-5233)
- Батршина Лилия Александровна (ORCID: https://orcid.org/0009-0008-4377-2453)
- E. A. Romanenko (ORCID: https://orcid.org/0009-0009-0243-966X)
Institutions
- Samara State Medical University (RU)
- Samara Regional Clinical Hospital named after V.D. Seredavina (RU)
Publication Details
- Journal
- Экспериментальная и клиническая гастроэнтерология
- Published
- 2026-11-18
- DOI
- https://doi.org/10.31146/1682-8658-ecg-248-4-213-220
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00